Healthcare System Readiness for a Paradigm Shift to the Early Diagnosis of Alzheimer’s Disease
Pierre Krolak-Salmon, MD, PhD, describes the benefits of a timely diagnosis of Alzheimer’s disease, alongside the major system constraints which are acting as barriers to the early diagnosis of the disease. He then highlights some possible options for reducing system constraints, to ready the system for the early diagnosis of Alzheimer’s disease. The symposium closes with a panel discussion summarizing the learnings from the patient case, multidisciplinary team working, and creating a referral network.
Key Learning Objectives for Biogen’s EAN 2020 Symposium:
- Understand the value of an early diagnosis of Alzheimer’s disease
- Gain insights on how comprehensive cognitive assessment tools and fluid and imaging biomarkers can be used to achieve an accurate and timely diagnosis of mild cognitive impairment due to Alzheimer’s disease
- Assess the current healthcare system readiness for a paradigm shift to early diagnosis
Disclosure: All panelists received honoraria from Biogen for participation in this symposium.
Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.